Global Medical Office Dialogues Podcast Por Fresenius Medical Care Global Medical Office arte de portada

Global Medical Office Dialogues

Global Medical Office Dialogues

De: Fresenius Medical Care Global Medical Office
Escúchala gratis

OFERTA POR TIEMPO LIMITADO. Obtén 3 meses por US$0.99 al mes. Obtén esta oferta.
Global Medical Office Dialogues, is an interview feature podcast. Frank Maddux, MD, FACP, Global Chief Medical Officer for Fresenius Medical Care, talks with a diverse group of thought leaders in science, medicine and current events. Through in-depth dialogue and discussion, we take a deeper look at important topics from many different angles and perspectives.Fresenius Medical Care Ciencia Enfermedades Físicas Higiene y Vida Saludable
Episodios
  • Predicting population trends in kidney health using advanced mathematical modeling with Doris Fuertinger, PhD
    Oct 23 2024

    Dr. Doris Fuertinger, Fresenius Medical Care’s Head of Computational Medicine, discusses the use of science-based systemic modeling tools to test a spectrum of hypotheses about the future impact of novel therapeutic interventions on populations with kidney disease.

    Más Menos
    29 m
  • Generative AI / Benefits and risk in Healthcare with Dr. Hanjie Zhang
    Sep 13 2024

    Generative AI represents a paradigm shift in the landscape of healthcare, offering unprecedented potential to revolutionize patient care, diagnosis, and treatment methodologies. However, amid its promising advancements substantial and daunting risks remain. Dr. Hanjie Zhang, Senior Director of computational statistics and artificial Intelligence at the Renal Research Institute in New York discusses the benefits and risks of Generative AI in healthcare.

    Más Menos
    27 m
  • Prof. Giovanni Strippoli, MD, discusses the CONVINCE Study in the context of existing evidence on hemodiafiltration
    Aug 28 2024

    Dr. Giovanni Strippoli, Professor of Nephrology at University of Bari, Italy, discusses how the CONVINCE study results will contribute to reaching a higher level of certainty regarding the comparative efficacy of hemodiafiltration (HDF) versus HD in people with end-stage kidney disease.

    Más Menos
    31 m
Todavía no hay opiniones